A unique set of SH3–SH3 interactions controls IB1 homodimerization

Islet‐brain 1 (IB1 or JIP‐1) is a scaffold protein that interacts with components of the c‐Jun N‐terminal kinase (JNK) signal‐transduction pathway. IB1 is expressed at high levels in neurons and in pancreatic β‐cells, where it controls expression of several insulin‐secretory components and secretion. IB1 has been shown to homodimerize, but neither the molecular mechanisms nor the function of dimerization have yet been characterized. Here, we show that IB1 homodimerizes through a novel and unique set of Src homology 3 (SH3)–SH3 interactions. X‐ray crystallography studies show that the dimer interface covers a region usually engaged in PxxP‐mediated ligand recognition, even though the IB1 SH3 domain lacks this motif. The highly stable IB1 homodimer can be significantly destabilized in vitro by three individual point mutations directed against key residues involved in dimerization. Each mutation reduces IB1‐dependent basal JNK activity in 293T cells. Impaired dimerization also results in a reduction in glucose transporter type 2 expression and in glucose‐dependent insulin secretion in pancreatic β‐cells. Taken together, these results indicate that IB1 homodimerization through its SH3 domain has pleiotropic effects including regulation of the insulin secretion process.

[1]  M. Kjeldgaard,et al.  O: A Macromolecule Modeling Environment , 1990 .

[2]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[3]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[4]  F. Richards,et al.  Stability and peptide binding affinity of an SH3 domain from the Caenorhabditis elegans signaling protein Sem‐5 , 1994, Protein science : a publication of the Protein Society.

[5]  Hongtao Yu,et al.  Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.

[6]  Michael J. Eck,et al.  Structure of the regulatory domains of the Src-family tyrosine kinase Lck , 1994, Nature.

[7]  T. L. Collins,et al.  Role of the Lck Src Homology 2 and 3 Domains in Protein Tyrosine Phosphorylation* , 1996, The Journal of Biological Chemistry.

[8]  M E Greenberg,et al.  A cytoplasmic inhibitor of the JNK signal transduction pathway. , 1997, Science.

[9]  G. Bricogne,et al.  [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. , 1997, Methods in enzymology.

[10]  Wendell A. Lim,et al.  How Src exercises self-restraint , 1997, Nature Structural Biology.

[11]  G. Waeber,et al.  IB1, a JIP-1-related Nuclear Protein Present in Insulin-secreting Cells* , 1998, The Journal of Biological Chemistry.

[12]  E. Elion.  Routing MAP Kinase Cascades , 1998, Science.

[13]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[14]  J. Yasuda,et al.  A mammalian scaffold complex that selectively mediates MAP kinase activation. , 1998, Science.

[15]  Andrea Musacchio,et al.  A novel peptide–SH3 interaction , 1999, The EMBO journal.

[16]  Roger J. Davis,et al.  The JIP Group of Mitogen-Activated Protein Kinase Scaffold Proteins , 1999, Molecular and Cellular Biology.

[17]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[18]  A. Charollais,et al.  Subcellular distribution and function of Rab3A, B, C, and D isoforms in insulin-secreting cells. , 1999, Molecular endocrinology.

[19]  G. Waeber,et al.  IB1 Reduces Cytokine-induced Apoptosis of Insulin-secreting Cells* , 2000, The Journal of Biological Chemistry.

[20]  M. Sudol,et al.  The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Stefan M. Larson,et al.  The identification of conserved interactions within the SH3 domain by alignment of sequences and structures , 2000, Protein science : a publication of the Protein Society.

[22]  M Dickens,et al.  Interaction of a Mitogen-Activated Protein Kinase Signaling Module with the Neuronal Protein JIP3 , 2000, Molecular and Cellular Biology.

[23]  C. Dina,et al.  The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes , 2000, Nature Genetics.

[24]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[25]  J. Blenis,et al.  Cargo of Kinesin Identified as Jip Scaffolding Proteins and Associated Signaling Molecules , 2001, The Journal of cell biology.

[26]  D. Meyer,et al.  Mixed lineage kinase‐dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components , 2001, The EMBO journal.

[27]  D. Schorderet,et al.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. , 2001, Diabetes.

[28]  P. Rakic,et al.  Requirement of the JIP1 scaffold protein for stress-induced JNK activation. , 2001, Genes & development.

[29]  Gary D Bader,et al.  A Combined Experimental and Computational Strategy to Define Protein Interaction Networks for Peptide Recognition Modules , 2001, Science.

[30]  D. Schorderet,et al.  Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of β-Cell Death , 2001 .

[31]  K. Gallo,et al.  Autoinhibition of Mixed Lineage Kinase 3 through Its Src Homology 3 Domain* , 2001, The Journal of Biological Chemistry.

[32]  B. Mayer,et al.  SH3 domains: complexity in moderation. , 2001, Journal of cell science.

[33]  R. A. Etten,et al.  Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain , 2001, Oncogene.

[34]  Kenji Ogura,et al.  Novel recognition mode between Vav and Grb2 SH3 domains , 2001, The EMBO journal.

[35]  Sarah A. Teichmann,et al.  Principles of protein-protein interactions , 2002, ECCB.

[36]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[37]  U. Heinemann,et al.  An Src Homology 3-like Domain Is Responsible for Dimerization of the Repressor Protein KorB Encoded by the Promiscuous IncP Plasmid RP4* , 2002, The Journal of Biological Chemistry.

[38]  J. Haefliger,et al.  The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium. , 2002, Journal of cell science.

[39]  L. D’Adamio,et al.  Amyloid β Protein Precursor (AβPP), but Not AβPP-like Protein 2, Is Bridged to the Kinesin Light Chain by the Scaffold Protein JNK-interacting Protein 1* , 2003, Journal of Biological Chemistry.

[40]  A. Whitmarsh,et al.  The JNK-interacting Protein-1 Scaffold Protein Targets MAPK Phosphatase-7 to Dephosphorylate JNK* , 2003, The Journal of Biological Chemistry.

[41]  A. Vercelli,et al.  A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia , 2003, Nature Medicine.

[42]  Crystallization and preliminary crystallographic characterization of an SH3 domain from the IB1 scaffold protein. , 2003, Acta crystallographica. Section D, Biological crystallography.

[43]  K. Miyazawa,et al.  A Scaffold Protein JIP-1b Enhances Amyloid Precursor Protein Phosphorylation by JNK and Its Association with Kinesin Light Chain 1* , 2003, Journal of Biological Chemistry.

[44]  M. Lewitzky,et al.  Structural basis for SH3 domain‐mediated high‐affinity binding between Mona/Gads and SLP‐76 , 2003, The EMBO journal.

[45]  L. D’Adamio,et al.  Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. , 2003, The Journal of biological chemistry.

[46]  R. Yacobi,et al.  Autoinhibition of Bcr-Abl through Its SH3 Domain , 2003, Molecular Cell.

[47]  Peer Bork,et al.  SMART 4.0: towards genomic data integration , 2004, Nucleic Acids Res..

[48]  A. Whitmarsh,et al.  Docking Interactions in the c-Jun N-terminal Kinase Pathway* , 2004, Journal of Biological Chemistry.

[49]  Sam-Yong Park,et al.  Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125 , 2004, The EMBO journal.